Schürmann M - Search Results

1

p53 Pathway Inactivation Drives SMARCB1-deficient p53-wildtype Epithelioid Sarcoma Onset Indicating Therapeutic Vulnerability Through MDM2 Inhibition.

Oppel F, Shao S, Gendreizig S, Zimmerman MW, Schürmann M, Flavian VF, Goon P, Chi SN, Aster JC, Sudhoff H, Look AT. Oppel F, et al. Among authors: schurmann m. Mol Cancer Ther. 2022 Nov 3;21(11):1689-1700. doi: 10.1158/1535-7163.MCT-21-0770. Mol Cancer Ther. 2022. PMID: 36099437

2

Specific Targeting of Oncogenes Using CRISPR Technology.

Oppel F, Schürmann M, Goon P, Albers AE, Sudhoff H. Oppel F, et al. Among authors: schurmann m. Cancer Res. 2018 Oct 1;78(19):5506-5512. doi: 10.1158/0008-5472.CAN-18-0571. Epub 2018 Sep 7. Cancer Res. 2018. PMID: 30194069

3

Viral and Clinical Oncology of Head and Neck Cancers.

Goon P, Schürmann M, Oppel F, Shao S, Schleyer S, Pfeiffer CJ, Todt I, Brasch F, Scholtz LU, Göerner M, Sudhoff H. Goon P, et al. Among authors: schurmann m. Curr Oncol Rep. 2022 Jul;24(7):929-942. doi: 10.1007/s11912-022-01263-7. Epub 2022 Mar 26. Curr Oncol Rep. 2022. PMID: 35347592 Free PMC article. Review.

4

An Effective Primary Head and Neck Squamous Cell Carcinoma In Vitro Model.

Oppel F, Shao S, Schürmann M, Goon P, Albers AE, Sudhoff H. Oppel F, et al. Among authors: schurmann m. Cells. 2019 Jun 7;8(6):555. doi: 10.3390/cells8060555. Cells. 2019. PMID: 31181618 Free PMC article.

5

Stem Cell-Induced Inflammation in Cholesteatoma is Inhibited by the TLR4 Antagonist LPS-RS.

Schürmann M, Greiner JFW, Volland-Thurn V, Oppel F, Kaltschmidt C, Sudhoff H, Kaltschmidt B. Schürmann M, et al. Cells. 2020 Jan 14;9(1):199. doi: 10.3390/cells9010199. Cells. 2020. PMID: 31947538 Free PMC article.

6

Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism.

Schürmann M, Oppel F, Shao S, Volland-Thurn V, Kaltschmidt C, Kaltschmidt B, Scholtz LU, Sudhoff H. Schürmann M, et al. Cell Commun Signal. 2021 Feb 24;19(1):25. doi: 10.1186/s12964-020-00690-y. Cell Commun Signal. 2021. PMID: 33627146 Free PMC article.

7

Review of potential medical treatments for middle ear cholesteatoma.

Schürmann M, Goon P, Sudhoff H. Schürmann M, et al. Cell Commun Signal. 2022 Sep 19;20(1):148. doi: 10.1186/s12964-022-00953-w. Cell Commun Signal. 2022. PMID: 36123729 Free PMC article. Review.

8

[Perspectives of genome editing in otorhinolaryngology].

Oppel F, Schürmann M, Shao S, Kaltschmidt B, Kaltschmidt C, Sudhoff H. Oppel F, et al. Among authors: schurmann m. HNO. 2019 Mar;67(3):184-189. doi: 10.1007/s00106-019-0613-y. HNO. 2019. PMID: 30689007 Review. German.

9

The Therapeutic Effect of 1,8-Cineol on Pathogenic Bacteria Species Present in Chronic Rhinosinusitis.

Schürmann M, Oppel F, Gottschalk M, Büker B, Jantos CA, Knabbe C, Hütten A, Kaltschmidt B, Kaltschmidt C, Sudhoff H. Schürmann M, et al. Front Microbiol. 2019 Oct 22;10:2325. doi: 10.3389/fmicb.2019.02325. eCollection 2019. Front Microbiol. 2019. PMID: 31708879 Free PMC article.

10

Mouthrinses against SARS-CoV-2: anti-inflammatory effectivity and a clinical pilot study.

Schürmann M, Aljubeh M, Tiemann C, Sudhoff H. Schürmann M, et al. Eur Arch Otorhinolaryngol. 2021 Dec;278(12):5059-5067. doi: 10.1007/s00405-021-06873-8. Epub 2021 May 22. Eur Arch Otorhinolaryngol. 2021. PMID: 34021807 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

293 results

Search Page